Cargando…
Single Institutional Experience with GM1 Gangliosidosis: Clinical and Laboratory Results of 14 Patients
BACKGROUND: GM1 gangliosidosis is an autosomal recessive lysosomal storage disease caused by biallelic mutations in the GLB1 gene. Neurodegeneration, hypotonia, visceromegaly, macular cherry-red spots, skeletal dysplasia, and coarse and dysmorphic face are the major clinical features. AIMS: To evalu...
Autores principales: | Akar, Halil Tuna, Yıldız, Yılmaz, Güvenkaya, Gökhan, Çıkı, Kısmet, Kahraman, Ayşe Burcu, Erdal, İzzet, Coşkun, Turgay, Dursun, Ali, Sivri, Hatice Serap, Tokatlı, Ayşegül |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469672/ https://www.ncbi.nlm.nih.gov/pubmed/35965426 http://dx.doi.org/10.4274/balkanmedj.galenos.2022.2022-3-75 |
Ejemplares similares
-
COVID-19 in inherited metabolic disorders: Clinical features and risk factors for disease severity
por: Kahraman, Ayca Burcu, et al.
Publicado: (2023) -
Genetics and Therapies for GM2 Gangliosidosis
por: Cachón-González, María Begoña, et al.
Publicado: (2018) -
GM1 Gangliosidosis: Mechanisms and Management
por: Rha, Allisandra K, et al.
Publicado: (2021) -
Oral health status of children and young adults with maple syrup urine disease in Turkey
por: Ballikaya, Elif, et al.
Publicado: (2021) -
Hyperinsulinism May Be Underreported in Hypoglycemic Patients with Phosphomannomutase 2 Deficiency
por: Vurallı, Doğuş, et al.
Publicado: (2022)